Stockreport

Sanofi's BTK Progress, And Other News: The Good, Bad And Ugly Of Biopharma [Seeking Alpha]

IMMUNOMEDICS  (IMMU) 
Last immunomedics earnings: 2/27 04:00 pm Check Earnings Report
PDF SummarySanofi's BTK inhibitor shows promise in RRMS.Kiniksa announces positive data from a dermatology trial.Immunomedics receives approval for cancer drug.Sanofi Shows [Read more]